Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS‐ACTS Substudy

ConclusionsWithin this XANTUS cohort, switching from a VKA to rivaroxaban yielded statistically and clinically significant improvements in ACT burden and benefit scores.

Source: Clinical Cardiology - June 29, 2016 Category: Cardiology Authors: Craig I. Coleman, Sylvia Haas, Alexander G.G. Turpie, Silvia Kuhls, Susanne Hess, Thomas Evers, Pierre Amarenco, Paulus Kirchhof, A. John Camm, Tags: Clinical Investigations Source Type: research